Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: do we need genetics for clinical decisions?

von Kodolitsch, Y., Rybczynski, M., Bernhardt, A., Mir, T. S., Treede, H., Dodge-Khatami, A., et al. (2010). Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: do we need genetics for clinical decisions? European Journal for Vascular Medicine, 39(1), 17-32. doi:10.1024/0301-1526/a000002.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel
Alternativer Titel : Vasa

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
von Kodolitsch, Y., Autor
Rybczynski, M., Autor
Bernhardt, A., Autor
Mir, T. S., Autor
Treede, H., Autor
Dodge-Khatami, A., Autor
Robinson, P. N.1, Autor           
Sheikhzadeh, S., Autor
Reichenspurner, H., Autor
Meinertz, T., Autor
Affiliations:
1Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433557              

Inhalt

einblenden:
ausblenden:
Schlagwörter: bicuspid aortic valve FBN1 Loeys-Dietz syndrome Marfan syndrome NOTCH1 TGFBR1
 Zusammenfassung: Marfan syndrome (MFS) is a disorder of the connective tissue that is inherited in an autosomal dominant fashion and that is classically caused by mutations in the gene coding for fibrillin-1, FBN1. The high mortality of untreated MFS results almost exclusively from aortic complications such as aortic dissection and rupture. However, more than half of patients with Marfan-like features do not have MFS, but have other diseases including inherited aortic aneurysms and dissections (TAAD). We elucidate the increasing spectrum of syndromes associated with Marfan-like features and discuss the clinical implications of these diseases. We performed a systematic review to tabulate all known inherited diseases and syndromes carrying a risk for thoracic aortic disease. We discuss evidence that different syndromes with different causative genes and mutations have different prognoses and profiles of cardiovascular manifestations. We conclude that future decisions for optimized management of patients with inherited TAAD require a comprehensive clinical and genetic work-up.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2010-02-01
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: European Journal for Vascular Medicine
  Alternativer Titel : Vasa
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 39 (1) Artikelnummer: - Start- / Endseite: 17 - 32 Identifikator: ISSN: 0301-1526